Table 1.

Clinical and cognitive results.

Neuropsychological test	SCD (N = 21)	Control (N = 18)	P value
MoCA-B	25.62 ± 2.31	25.44 ± 1.82	0.78
SCD-Q9	5.00 ± 1.80	2.33 ± 1.49	<0.01
HAMD	4.10 ± 3.79	1.83 ± 1.79	0.04
HAMA	4.62 ± 3.87	1.72 ± 2.32	<0.01
AVLT: long delayed recall	6.24 ± 1.64	6.33 ± 1.37	0.83
AVLT: recognition	21.90 ± 1.58	21.33 ± 1.46	0.30
STT-A	63.10 ± 14.88	61.33 ± 15.40	0.38
STT-B	140.81 ± 42.22	137.11 ± 38.89	0.50
AFT	18.90 ± 5.22	18.67 ± 5.09	0.91
BNT	25.38 ± 2.36	24.06 ± 3.23	0.18
GDS	2.33 ± 1.80	1.39 ± 1.42	0.12
FAQ	0.19 ± 0.68	0.06 ± 0.24	0.46

SCD: subjective cognitive decline; MoCA-B: Montreal Cognitive Assessment-Basic; SCD-Q9: 9-item Subjective Cognitive Decline Questionnaire; HAMD: Hamilton Depression Scale; HAMA: Hamilton Anxiety Scale; AVLT: Auditory Verbal Learning Test; STT: Shape Trail Test; AFT: Animal Fluency Test; BNT: Boston Naming Test; GDS: Geriatric Depression Scale; FAQ: Functional Activities Questionnaire.

Note: Values are mean ± SD. P values were obtained by performing analyses of covariance with age, gender and education as covariates.